Overview:
Osteoporosis is a bone disease that occurs when the body loses too much bone, makes too little bone, or both. As a result, bones become weak and can be broken by a fall or, in severe cases, sneezing or a minor bump. A lifelong lack of calcium plays a vital role in the development of osteoporosis. Although there is no cure for osteoporosis, proper treatment can help protect and strengthen bones. Osteoporosis treatment can help slow the breakdown of bone, and can spur the growth of new bone. Treatment includes medication, weight-bearing exercise, and a healthy diet to help prevent bone loss or strengthen weak bones. Some alternative therapies can also be used to treat osteoporosis. However, the goal of any alternative treatment is to manage or heal the condition without the use of medication.
Get Sample Report with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/1096
Key Market Drivers:
Increasing prevalence of osteoporosis worldwide is expected to augment the growth of the osteoporosis treatment market during the forecast period. For instance, according to the recent statistics from the International Osteoporosis Foundation, worldwide, one in three women over the age of 50 years and one in five men will experience osteoporotic fractures in their lifetime. Currently, more than 200 million people worldwide are suffering from osteoporosis.
Moreover, introduction of novel techniques to lower the prevalence of osteoporosis and raising public awareness about available drug or treatment for osteoporosis is also expected to fuel the growth of the osteoporosis treatment market. For instance, in April 2019, AMGA Foundation, in collaboration with Amgen, launched its Osteoporosis Best Practices Learning Collaborative, a 12-month initiative to help medical groups develop strategies to reduce fracture rates among patients with osteoporosis.
COVID-19 Impact Analysis:
It is acknowledged that the pandemic has caused profound disruption in the delivery of health services globally. The pandemic has also affected the management of some medical conditions, such as osteoporosis, as resources are diverted to cover urgent care to curb the spread of the virus. The pandemic has directly and indirectly affected osteoporosis diagnosis and treatment throughout the world. Moreover, osteoporosis drugs are safe and effective during the pandemic and should be continued whenever possible. This in turn is expected to aid in the growth of the osteoporosis treatment market over the forecast period.
Competitive Landscape:
Major players operating in the global osteoporosis treatment market are Pfizer Inc., Allergan Plc., GlaxoSmithKline Plc., Merck & Co AG, Novartis AG, EffRx Pharmaceuticals SA, F.Hoffmann La Roche AG, Asahi Kasei Corporation, Eli Lilly and Company, Pfenex Inc., Mylan Inc., Dr. Reddy’s Laboratories, Amgen Inc., Daiichi Sankyo Company Limited, and Teva Pharmaceutical Industries Ltd.
Get PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/1096
Key Takeaways:
The osteoporosis treatment market is expected to exhibit a CAGR of XX % during the forecast period owing to frequent launches and approvals of novel osteoporosis treatment drugs worldwide. For instance, in September 2021, Pharmanovia, in conjunction with their South African partner Adcock Ingram, launched OsteoApp, a medication app reminder for patients that is aimed at improving the management of osteoporosis.
Among regions, North America is expected to witness robust growth in the osteoporosis treatment market due to frequent launches and approvals of novel osteoporosis drugs and treatment in this region. For instance, Amgen and UCB announced that the U.S. Food and Drug Administration (FDA) approved EVENITY (romosozumab-aqqg) for the treatment of osteoporosis in postmenopausal women at high risk for fracture.
Europe is expected to witness significant growth in the osteoporosis treatment market due to frequent launches and approvals of novel osteoporosis drugs and treatment in this region. For instance, in August 2019, Gedeon Richter launched its biosimilar drug, named Terrosa, in Europe for the treatment of osteoporosis in men and women.
Buy This Complete A Business Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/insight/buy-now/1096
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- PEST Analysis
- Pipeline Analysis
- Product Approval
- Product Launch
- Collaboration-Acquisition
- Porter’s Five Forces Analysis
- Market Dynamics
- Global Osteoporosis Treatment Market, By Drug Type, 2016 – 2026 (US$ Bn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- Bisphosphonates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Segment Trends
- Alendronate
- Risedronate
- Ibandronate
- Zoledronic Acid
- Others
- Calcitonin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Hormone Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Selective Estrogen Receptor Modulators (SERMs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Parathyroid Hormone-Related Protein (PTHrP) Analog
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Rank Ligand (RANKL) Inhibitor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Introduction
- Global Osteoporosis Treatment Market, By Route of Administration, 2016 – 2026 (US$ Bn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Introduction
- Global Osteoporosis Treatment Market, By Distribution Channel, 2016 – 2026 (US$ Bn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Introduction
- Global Osteoporosis Treatment Market, By Region, 2016 – 2026 (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
- Central Africa
- South Africa
- North Africa
- Middle East
- Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Daiichi Sankyo Company Limited.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dr Reddy’s Laboratories
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfenex Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Asahi Kasei Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- F.Hoffmann La Roche
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- EffRx Pharmaceuticals SA
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline Plc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Allergan plc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Section
- References
- Research Methodology
- About us and Sales Contact
Inquire more about this report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1096
Our analysts are experts in this field with years of experience. We at Coherent Market Insights maintain the highest level of accuracy and transparency in the report. The primary and secondary resources used in the report are taken from reliable and high authority sources to deliver 100% accurate and trusted data.
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837